DRAXXIN® (tulathromycin) Injectable Solution is a unique, novel treatment that delivers:
Superior efficacy to treat BRD when compared with Baytril®, Nuflor® and Micotil® in field studies.1,2,3,6
Convenient, full course of therapy in a single dose.
Effectiveness against the four major BRD pathogens.
Mannheimia (Pasteurella) haemolytica
Pasteurella multocida
Histophilus somni (Haemophilus somnus)
Mycoplasma bovis
Excellent first BRD treatment response.1,2,3,6
Remarkably lower mortalities and chronics due to BRD. 1,2,3
Effective control of BRD in cattle at high risk of developing BRD.3
The Single Dose Convenience You Want
Resources & Technical Information
Efficacy of DRAXXIN®, followed by 7-,10-, or 14-day post-treatment intervals, against naturally occurring bovine respiratory disease
Efficacy of DRAXXIN® (tulathromycin) Injectable Solution for treatment of experimentally induced Mycoplasma bovis respiratory infection in calves
Important Safety Information
Draxxin has a pre-slaughter withdrawal time of 18 days. Do not use in female dairy cattle 20 months of age or older. Do not use in calves to be processed for veal. Effects on reproductive performance, pregnancy and lactation have not been determined.